QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2015     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Driver Circuit System for Temperature Control of Micro-hotplates: Measurement and Strategy 会议论文 11th IEEE International Conference on ASIC (ASICON), Chengdu, PEOPLES R CHINA, 2015-01-01 作者:  Wu, Jiarui;  Yu, Jun;  Liang, Jiaming;  Shi, Zhan;  Li, Zhongzhou 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/09 Improvement of the charge pump for Maneatis PLLs 会议论文 11th IEEE International Conference on ASIC (ASICON), Chengdu, PEOPLES R CHINA, 2015-01-01 作者:  Shi, Zhan;  Tang, Zhenan;  Yang, Fan;  Wu, Jiarui 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/09 Autologous peripheral blood stemcell mobilization following dose-adjustedcyclophosphamide, doxorubicin, vincristine,and prednisolone chemotherapy alone orin combination with rituximab in treatinghigh-risk non-Hodgkin's lymphoma 期刊论文 2015, 期号: 11, 页码: 522-530 作者:  Yuankai Shi;  Ping Zhou;  Xiaohong Han;  Xiaohui He;  Shengyu Zhou 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 CRM1 as a new therapeutic target for non-Hodgkin lymphoma 期刊论文 2015, 卷号: 39, 期号: 1, 页码: 38-46 作者:  Han, Xiaohong;  Wang, Jianfei;  Shen, Yinchen;  Zhang, Ningning;  Wang, Shuai 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 CRM1  CRM1 inhibitor  Non-Hodgkin lymphoma   Absolute monocyte count is a prognostic indicator in a patient with diffuse large B-cell lymphoma after autologous peripheral blood stem cell transplant 期刊论文 2015, 卷号: 56, 期号: 2, 页码: 515-517 作者:  Mo, Hongnan;  Shi, Yuankai;  Han, Xiaohong;  Zhou Shengyu;  He Xiaohui 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 Antitumor Efficacy of Histone Deacetylase Inhibitor or in Combination with EGFR-TKI in Non-Small Cell Lung Cancer Cell Lines 期刊论文 2015, 卷号: 10, 期号: 9, 页码: S484-S484 作者:  Han, Xiaohong;  Zhang, Ningning;  Yao, Jiarui;  Shi, Yuankai 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Epidermal growth factor receptor tyrosine kinase inhibitor  non-small cell lung cancer  histone deacetylase inhibitor  antitumor efficacy   Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma 期刊论文 2015, 卷号: 34, 期号: 11, 页码: 522-30 作者:  Shi, Yuankai;  Zhou, Ping;  Han, Xiaohong;  He, Xiaohui;  Zhou, Shengyu 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Stem cell transplantation  Mobilization  CHOP regimen  Rituximab  Non-Hodgkin's lymphoma